Skip to main content
UNIVERSAL BIOSENSORS INC. logo

UNIVERSAL BIOSENSORS INC. — Investor Relations & Filings

Ticker · UBI ISIN · AU000000UBI2 LEI · 9845006ABC71C514C696 ASX Manufacturing
Open in API
Filings indexed 958 across all filing types
Latest filing 2025-05-11 Interim / Quarterly Rep…
Country AU Australia
Listing ASX UBI

About UNIVERSAL BIOSENSORS INC.

https://universalbiosensors.com/

Universal Biosensors Inc. specializes in the research, development, and manufacture of electrochemical biosensor systems for point-of-care testing. The company leverages a proprietary technology platform to deliver rapid, accurate diagnostic results across various sectors, including healthcare and food and beverage. Its core product offerings include the Xprecia Prime system for coagulation monitoring and the Sentia platform, which provides automated laboratory-grade analysis for the wine industry, measuring parameters such as free sulfur dioxide, malic acid, and glucose. Universal Biosensors focuses on miniaturizing complex laboratory tests into portable, easy-to-use devices, utilizing multi-layer test strip architecture and sophisticated electrochemical detection methods to improve testing efficiency and accessibility in decentralized settings.

Recent filings

Filing Released Lang Actions
Q1 2025 Results 31 pages 350.5KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and explicitly states it is a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended March 31, 2025. It contains detailed unaudited consolidated condensed financial statements, including balance sheets, statements of comprehensive income, changes in stockholders' equity, cash flows, and notes to the financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-05-11 English
Q1 2025 Results Presentation 8 pages 431.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Universal Biosensors, Inc. Update Q1 2025' and contains detailed business updates including sales growth, product development, capital raise plans, distribution agreements, and capital structure information. It includes forward-looking statements, disclaimers, and operational metrics for Q1 2025. The document is about 13,851 characters long, which is substantial and contains substantive financial and operational data for the quarter. It is not a full annual report (10-K) but rather a quarterly business update with financial and operational performance details. It is not a simple announcement or a presentation for an AGM or investor meeting, but a comprehensive quarterly update. Therefore, it fits best as an Interim / Quarterly Report (IR).
2025-05-11 English
Notification regarding unquoted securities - UBI 9 pages 30.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options under an employee incentive scheme. It includes specifics such as the number of securities issued, exercise prices, expiry dates, and mentions key management personnel receiving securities. The document is a formal notification of new securities issued, including compliance with ASX listing rules and shareholder approval. This fits the definition of a Share Issue/Capital Change announcement, as it reports on new share-related securities being issued and changes in capital structure. The document is not a full financial report, earnings release, or management discussion, nor is it a proxy statement or voting result. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and detail support a high confidence level.
2025-05-11 English
Results of 2025 Annual General Meeting 2 pages 260.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the results of the 2025 Annual General Meeting (AGM) of Universal Biosensors, Inc. It references the passing of resolutions at the AGM, including election of directors and approval of executive compensation, consistent with shareholder voting outcomes. The document is relatively short (3644 characters) and primarily reports voting results rather than providing detailed financial data or full meeting materials. It explicitly states it is in accordance with ASX Listing Rule 3.13.2, which pertains to disclosure of voting results. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-11 English
March 2025 Quarterly Activity Report and Appendix 4C 6 pages 373.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'March 2025 Quarterly Activity Report' and includes an ASX Appendix 4C cash flow report for the quarter ended 31 March 2025. It contains detailed quarterly financial data including cash flows from operating, investing, and financing activities, as well as commentary on business activities and cash position. The presence of actual financial statements and substantive financial data for a quarter indicates this is a quarterly financial report. The document is not a brief announcement or a certification but a comprehensive quarterly report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-04-29 English
2025 Notice of Meeting / Proxy Statement 48 pages 2.1MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, which is used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It includes detailed information about the meeting date, proposals to be voted on (such as election of directors, option grants, and advisory votes on executive compensation), voting instructions, and other related materials. The document explicitly states it is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 and is definitive, not preliminary. It also references the availability of the Annual Report (Form 10-K) but does not contain the report itself. The content aligns with the definition of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. Therefore, the correct classification is PSI with high confidence.
2025-04-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.